21.10.2020
Valneva Announces Positive Initial Results for Second Phase 2 Study of Lyme Disease Vaccine Candidate VLA15
We also work with the Austrian regional development agency to increase the number of life sciences companies settling from abroad as well as the Austrian Federal Chamber of Commerce, supporting young companies in their ventures abroad.
= LISA News